Ilgam Khalilov

This study demonstrates that gene therapy targeting GluK2 reduces seizures in TLE models and patient-derived slices.

This study shows that impaired KCC2 phosphorylation in mice leads to neuronal network dysfunction and neurodevelopmental issues, with some effects reversible by bumetanide treatment.

This study shows that bumetanide reduces depression-like behavior after brain trauma in mice by preserving interneurons and neurogenesis.